Remove Containment Remove Doctors Remove Marketing Remove Research
article thumbnail

Using the Internet to reach doctors, numbers don’t matter. What you have to say and how you say are more important.

World of DTC Marketing

According to research from HealthLink Dimensions, more than a third of physicians reported using social networks to communicate with their professional peers, and 59% said they see the value in social media and plan to use it as a resource in the future. When using the Internet to reach doctors, numbers don’t matter.

Doctors 143
article thumbnail

The social media problem for healthcare

World of DTC Marketing

SUMMARY: The Facebook whistleblower lawsuit can be summed up in one sentence: Facebook prioritizes engagement above all else because it leads to more profits even if that engagement containing inflammatory information. TV will still be the first choice for many DTC marketers, but digital is increasing even though 50% of that money is wasted.

Branding 224
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CIMC Enric’s Subsidiary Deploys Vaccine Storage Market To Carry out R&D of Cryogenic Liquid Nitrogen Biological Container

The Pharma Data

Ltd (“ CIMC Sanctum “) recently started R&D of liquid nitrogen biological containers for long-term cryogenic storage of vaccines, stem cells, plasma, semen, embryos and various tissues and organs for the needs of the biomedical industry. The company has set up a comprehensive marketing network with global coverage.

article thumbnail

The US biosimilar market: Predictions for 2021

pharmaphorum

It has been five years since the first biosimilar launched in United States market—marking the first steps in expanding access to innovative biologic-based treatments that help patients manage and treat difficult illnesses such as cancer, rheumatoid arthritis, and other life-altering diseases. million patients.

article thumbnail

Exploring the Market Potential of the Upcoming Therapies for the Myasthenia Gravis

Delveinsight

There are several therapies in the market to address the Myasthenia Gravis burden, and many companies are still working on their drug candidates to cope with Myasthenia Gravis. The current Myasthenia Gravis therapeutics market has many FDA-approved drugs for the treatment of Myasthenia Gravis. Myasthenia Gravis Approved Therapies.

article thumbnail

Since when did we believe that people would do what’s medically right?

World of DTC Marketing

Virtual doctor visits had been declining as I forecasted they would, but now they could climb again. On Facebook, researchers at the left-leaning advocacy group Avaaz ran an experiment in June in which two brand-new accounts it set up were recommended 109 pages containing anti-vaccine information in just two days.

article thumbnail

AI meets RWE: The future of drug assessment?

pharmaphorum

This article appears in out digital magazine Deep Dive: Market Access 2021. You realise that when you talk to doctors and listen to their real-life experiences. One problem is that most RWE is contained in inflexible, siloed databases. Read below for a preview: Real world evidence (RWE) is rapidly evolving.

Drugs 82